Silver Spring, Maryland–(ENEWSPF)–September 17, 2015. The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.
FDA Approves New Drug to Treat Schizophrenia and Bipolar Disorder
More in Health and Fitness:
